The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

IQVIA Holdings Inc. (NYSE:IQV) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 3, analysts at RBC Capital initiated coverage of IQVIA Holdings Inc. (NYSE:IQV) with an Outperform ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg ...

The first experimental use of chemotherapy was conducted in 1942 using nitrogen mustard to treat non-Hodgkin lymphoma, 1,2 marking the beginning of modern chemotherapy development, the transition from ...

Acurx Pharmaceuticals (ACXP) stock jumped 218% after announcing a clinical trial for ibezapolstat, which showed 96% cure rate for C. difficile infection.

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...